Daniel Engelman

3.9k total citations
68 papers, 1.8k citations indexed

About

Daniel Engelman is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Sociology and Political Science. According to data from OpenAlex, Daniel Engelman has authored 68 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Infectious Diseases, 29 papers in Public Health, Environmental and Occupational Health and 22 papers in Sociology and Political Science. Recurrent topics in Daniel Engelman's work include Dermatological diseases and infestations (45 papers), Streptococcal Infections and Treatments (24 papers) and Cultural Competency in Health Care (22 papers). Daniel Engelman is often cited by papers focused on Dermatological diseases and infestations (45 papers), Streptococcal Infections and Treatments (24 papers) and Cultural Competency in Health Care (22 papers). Daniel Engelman collaborates with scholars based in Australia, United Kingdom and Fiji. Daniel Engelman's co-authors include Andrew C. Steer, R. J. Hay, Shelley F. Walton, Roderick J. Hay, Margot Whitfeld, O. Chosidow, L. Claire Fuller, John Kaldor, Oliver Sokana and Michael Marks and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and European Heart Journal.

In The Last Decade

Daniel Engelman

67 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Engelman Australia 22 1.5k 462 400 315 270 68 1.8k
Margot Whitfeld Australia 20 1.3k 0.9× 265 0.6× 328 0.8× 215 0.7× 416 1.5× 51 1.7k
Loïc Epelboin French Guiana 22 899 0.6× 763 1.7× 70 0.2× 386 1.2× 281 1.0× 153 1.6k
Lucia Romani Australia 16 1.1k 0.7× 200 0.4× 322 0.8× 99 0.3× 214 0.8× 40 1.2k
Sékéné Badiaga France 18 495 0.3× 293 0.6× 34 0.1× 264 0.8× 313 1.2× 53 1.0k
Jean Vincelette Canada 25 885 0.6× 389 0.8× 161 0.4× 1.1k 3.5× 76 0.3× 72 2.1k
Miguel J. Martínez Spain 23 678 0.5× 333 0.7× 25 0.1× 492 1.6× 51 0.2× 86 1.5k
Isabelle Bonmarin France 22 422 0.3× 130 0.3× 26 0.1× 698 2.2× 43 0.2× 46 1.2k
Thérèse Kearns Australia 15 430 0.3× 199 0.4× 77 0.2× 106 0.3× 205 0.8× 40 756
Yuzo Arima Japan 21 484 0.3× 471 1.0× 123 0.3× 250 0.8× 74 0.3× 61 1.1k
Dimie Ogoina Nigeria 19 378 0.3× 152 0.3× 62 0.2× 858 2.7× 52 0.2× 59 1.8k

Countries citing papers authored by Daniel Engelman

Since Specialization
Citations

This map shows the geographic impact of Daniel Engelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Engelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Engelman more than expected).

Fields of papers citing papers by Daniel Engelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Engelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Engelman. The network helps show where Daniel Engelman may publish in the future.

Co-authorship network of co-authors of Daniel Engelman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Engelman. A scholar is included among the top collaborators of Daniel Engelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Engelman. Daniel Engelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rwebembera, Joselyn, Natalie Carvalho, Allison R. Webel, et al.. (2024). Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial). American Heart Journal. 275. 74–85. 1 indexed citations
2.
Engelman, Daniel, Rajesh Singh, Anneke Grobler, et al.. (2024). Ivermectin-Based Mass Drug Administration for Scabies in Northern India: A Single-Arm Community Intervention Trial. Open Forum Infectious Diseases. 11(10). ofae573–ofae573.
3.
Thornley, Simon, Gerhard Sundborn, Daniel Engelman, et al.. (2023). Children's scabies survey indicates high prevalence and misdiagnosis in Auckland educational institutions. Journal of Paediatrics and Child Health. 59(12). 1296–1303. 4 indexed citations
4.
Kearns, Thérèse, Helen J. Mayfield, Sarah Sheridan, et al.. (2023). Scabies prevalence after ivermectin-based mass drug administration for lymphatic filariasis, Samoa 2018–2019. PLoS neglected tropical diseases. 17(8). e0011549–e0011549. 3 indexed citations
5.
Oliver, Jane, Michael M.H. Cheung, Sarah A. Hope, et al.. (2022). Acute rheumatic fever and rheumatic heart disease in children and adolescents in Victoria, Australia. Journal of Paediatrics and Child Health. 59(2). 352–359. 9 indexed citations
6.
Rafai, Eric, Mike Kama, Meciusela Tuicakau, et al.. (2022). Costs of mass drug administration for scabies in Fiji. PLoS neglected tropical diseases. 16(2). e0010147–e0010147. 4 indexed citations
7.
Engelman, Daniel, et al.. (2022). Scabies epidemiology in health care centers for refugees and asylum seekers in Greece. PLoS neglected tropical diseases. 16(6). e0010153–e0010153. 17 indexed citations
8.
Jenney, Adam, Daniel Engelman, Lucia Romani, et al.. (2021). Prospective surveillance for invasive Staphylococcus aureus and group A Streptococcus infections in a setting with high community burden of scabies and impetigo. International Journal of Infectious Diseases. 108. 333–339. 5 indexed citations
9.
Tesfaye, Wubshet, Solomon Abrha, Gregory M. Peterson, et al.. (2021). Emerging Treatment Strategies for Impetigo in Endemic and Nonendemic Settings: A Systematic Review. Clinical Therapeutics. 43(6). 986–1006. 11 indexed citations
10.
Scheel, Amy, Mariana Mirabel, Maria Carmo Pereira Nunes, et al.. (2020). The inter-rater reliability and individual reviewer performance of the 2012 world heart federation guidelines for the echocardiographic diagnosis of latent rheumatic heart disease. International Journal of Cardiology. 328. 146–151. 8 indexed citations
11.
Marks, Michael, Lucia Romani, Oliver Sokana, et al.. (2019). Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin. Clinical Infectious Diseases. 70(8). 1591–1595. 30 indexed citations
12.
Beaton, Andrea, Emmy Okello, Daniel Engelman, et al.. (2019). Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial. American Heart Journal. 215. 95–105. 20 indexed citations
13.
Engelman, Daniel, et al.. (2017). Secondary prevention for screening detected rheumatic heart disease: opportunities to improve adherence. Transactions of the Royal Society of Tropical Medicine and Hygiene. 111(4). 154–162. 10 indexed citations
14.
Engelman, Daniel, Emmy Okello, Andrea Beaton, et al.. (2016). Evaluation of Computer-Based Training for Health Workers in Echocardiography for RHD. Global Heart. 12(1). 17–17. 11 indexed citations
15.
Engelman, Daniel, Gavin Wheaton, Joseph Kado, et al.. (2016). Screening-detected rheumatic heart disease can progress to severe disease. Heart Asia. 8(2). 67–73. 33 indexed citations
16.
Marks, Michael, Oliver Sokana, Anthony W. Solomon, et al.. (2016). The Prevalence of Scabies and Impetigo in the Solomon Islands: A Population-Based Survey. PLoS neglected tropical diseases. 10(6). e0004803–e0004803. 79 indexed citations
17.
Engelman, Daniel, Joseph Kado, Bo Reményi, et al.. (2016). Focused cardiac ultrasound screening for rheumatic heart disease by briefly trained health workers: a study of diagnostic accuracy. The Lancet Global Health. 4(6). e386–e394. 48 indexed citations
18.
Engelman, Daniel, Joseph Kado, Bo Reményi, et al.. (2015). Teaching focused echocardiography for rheumatic heart disease screening. Annals of Pediatric Cardiology. 8(2). 118–118. 21 indexed citations
19.
Marks, Michael, et al.. (2015). Long Term Control of Scabies Fifteen Years after an Intensive Treatment Programme. PLoS neglected tropical diseases. 9(12). e0004246–e0004246. 29 indexed citations
20.
Hay, R. J., Andrew C. Steer, Daniel Engelman, & Shelley F. Walton. (2012). Scabies in the developing world–-its prevalence, complications, and management. Clinical Microbiology and Infection. 18(4). 313–323. 245 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margot Whitfeld Breakdown of academic impact, for papers by Loïc Epelboin Breakdown of academic impact, for papers by Lucia Romani Breakdown of academic impact, for papers by Sékéné Badiaga Breakdown of academic impact, for papers by Jean Vincelette Breakdown of academic impact, for papers by Miguel J. Martínez Breakdown of academic impact, for papers by Isabelle Bonmarin Breakdown of academic impact, for papers by Thérèse Kearns Breakdown of academic impact, for papers by Yuzo Arima Breakdown of academic impact, for papers by Dimie Ogoina
Rankless by CCL
2026